Multiple Myeloma Posts Page 2 on Medivizor
Navigation Menu

Multiple Myeloma Posts on Medivizor

Evaluating ixazomib, cyclophosphamide and dexamethasone treatment for relapsed/refractory multiple myeloma

Posted by on Dec 22, 2018 in Multiple Myeloma | 0 comments

In a nutshell This article investigated the safety and effectiveness of combining ixazomib (Ninlaro), cyclophosphamide (Cytoxan) and dexamethasone (Decadron) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM). The authors concluded that the combination treatment is safe and gave...

Read More

Stem cell transplantation and lenalidomide improves survival of patients with multiple myeloma

Posted by on Dec 5, 2018 in Multiple Myeloma | 0 comments

In a nutshell This article investigated the safety and effectiveness of high-dose therapy with autologous stem cell transplantation (HDT-ASCT) and maintenance treatment (treatment meant to keep cancer from coming back) with lenalidomide (Revlimid) for patients with multiple myeloma. The authors concluded that this therapy is safe...

Read More

Is Daratumumab added to bortezomib plus dexamethasone better in treating multiple myeloma?

Posted by on Nov 28, 2018 in Multiple Myeloma | 0 comments

In a nutshell This article investigated the safety and effectiveness of adding daratumumab (Darzalex) to bortezomib (Velcade) and dexamethasone (Decadron) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM). The authors concluded that the addition of daratumumab is safe and gave the greatest benefit to...

Read More

How does elotuzumab affect pain and quality of life in non-responsive multiple myeloma?

Posted by on Nov 19, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the effects of adding elotuzumab to lenalidomide and dexamethasone to treat un-responsive multiple myeloma. The main finding was that patients treated with elotuzumab responded better to lenalidomide and dexamethasone. Some background Many patients respond well to treatment for multiple myeloma (MM). However some...

Read More

Thalidomide for Multiple Myeloma.

Posted by on Nov 7, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study aimed to compare the long-term effects of thalidomide (Immunoprin) to those of classic anti-cancer drugs in patients with recently diagnosed multiple myeloma. Thalidomide appeared effective but many patients experienced side-effects that affected treatment.  Some background Vincristine (Oncovin), doxorubicin...

Read More

The safety of elotuzumab, lenalidomide and dexamethasone in unresponsive multiple myeloma.

Posted by on Oct 18, 2018 in Multiple Myeloma | 0 comments

In a nutshell This paper compared the safety and effectiveness of elotuzumab (Empliciti) plus lenalidomide (Revlimid) and dexamethasone (Decadron) with lenalidomide and dexamethasone in unresponsive multiple myeloma. It was found that elotuzumab plus lenalidomide and dexamethasone was more effective than lenalidomide and dexamethasone alone. Some...

Read More